ASLAN Pharmaceuticals to implement ADS ratio change

Mar. 10, 2023 7:14 AM ETASLAN Pharmaceuticals Limited (ASLN)By: Khyathi Dalal, SA News Editor
  • ASLAN Pharmaceuticals (NASDAQ:ASLN) plans to change the ADS ratio to its ordinary shares, par value $0.01 per share, from one ADS representing five ordinary shares to one ADS representing 25 ordinary shares.
  • For the company’s existing ADS holders, the change in the ADS ratio will have the same effect as a one-for-five reverse ADS split.
  • The ratio change is effective Mar.13, 2023 after market opens.
  • As a result of the ADS ratio change, the ADS price is expected to increase proportionally.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.